For research use only. Not for therapeutic Use.
Convallatoxin(CAT: R030439) is a naturally occurring cardiac glycoside derived from plants like Convallaria majalis (lily of the valley). This bioactive compound is characterized by its steroidal core linked to sugar moieties, making it a potent inhibitor of Na⁺/K⁺-ATPase. Convallatoxin is widely studied in pharmacological and biochemical research for its effects on cardiac contractility, offering insights into treatments for conditions such as heart failure. Its high specificity and biological activity also make it a valuable tool for studying ion transport and cellular signaling pathways. With consistent quality and reliability, Convallatoxin supports cutting-edge research in cardiology and related fields.
Catalog Number | R030439 |
CAS Number | 508-75-8 |
Synonyms | (3β,5β)-3-[(6-Deoxy-α-L-mannopyranosyl)oxy]-5,14-dihydroxy-19-oxo-Card-20(22)-enolide; Convallaotoxin; Convallaton; Convallatoxine; Convallatoxoside; Convallotoxin; Corglycon; Corglycone; Corglykon; Korglykon; NSC 407808; Strophanthidin α-L-Rhamnosid |
Molecular Formula | C29H42O10 |
Purity | ≥95% |
Target | Vitamin D Related/Nuclear Receptor |
Storage | RT |
IUPAC Name | (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde |
InChI | InChI=1S/C29H42O10/c1-15-22(32)23(33)24(34)25(38-15)39-17-3-8-27(14-30)19-4-7-26(2)18(16-11-21(31)37-13-16)6-10-29(26,36)20(19)5-9-28(27,35)12-17/h11,14-15,17-20,22-25,32-36H,3-10,12-13H2,1-2H3/t15-,17-,18+,19-,20+,22-,23+,24+,25-,26+,27-,28-,29-/m0/s1 |
InChIKey | HULMNSIAKWANQO-JQKSAQOKSA-N |
SMILES | CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)O)O)O |